193 related articles for article (PubMed ID: 9990401)
1. Exacerbation of systemic lupus erythematosus induced by terbinafine.
Holmes S; Kemmett D
Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
[No Abstract] [Full Text] [Related]
2. Terbinafine-induced subacute cutaneous lupus erythematosus.
Brooke R; Coulson IH; al-Dawoud A
Br J Dermatol; 1998 Dec; 139(6):1132-3. PubMed ID: 9990400
[No Abstract] [Full Text] [Related]
3. Terbinafine-induced lupus erythematosus.
Murphy M; Barnes L
Br J Dermatol; 1998 Apr; 138(4):708-9. PubMed ID: 9640387
[No Abstract] [Full Text] [Related]
4. Subacute cutaneous lupus erythematosus associated with terbinafine.
Kasperkiewicz M; Anemüller W; Angelova-Fischer I; Rose C; Zillikens D; Fischer TW
Clin Exp Dermatol; 2009 Oct; 34(7):e403-4. PubMed ID: 19549237
[No Abstract] [Full Text] [Related]
5. Terbinafine as a cause of cutaneous lupus erythematosus.
McKellar G; Porter D; Burden D
Rheumatology (Oxford); 2004 Feb; 43(2):249. PubMed ID: 14739471
[No Abstract] [Full Text] [Related]
6. [Terbinafine-induced subacute cutaneous lupus erythematosus. Case report and review of the literature].
Matthes T; Hagedorn M
Hautarzt; 2004 Jul; 55(7):653-7. PubMed ID: 15146276
[TBL] [Abstract][Full Text] [Related]
7. Terbinafine-induced subacute cutaneous lupus erythematosus.
McKay DA; Schofield OM; Benton EC
Acta Derm Venereol; 2004; 84(6):472-4. PubMed ID: 15844640
[TBL] [Abstract][Full Text] [Related]
8. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.
Cetkovská P; Pizinger K
Int J Dermatol; 2006 Mar; 45(3):320-2. PubMed ID: 16533240
[TBL] [Abstract][Full Text] [Related]
9. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
Callen JP; Hughes AP; Kulp-Shorten C
Arch Dermatol; 2001 Sep; 137(9):1196-8. PubMed ID: 11559217
[TBL] [Abstract][Full Text] [Related]
10. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature.
Lorentz K; Booken N; Goerdt S; Goebeler M
J Dtsch Dermatol Ges; 2008 Oct; 6(10):823-7, 823-8. PubMed ID: 18564209
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous lupus erythematosus induced by terbinafine].
Møller M; Bygum A
Ugeskr Laeger; 2006 Dec; 168(50):4427-8. PubMed ID: 17217873
[TBL] [Abstract][Full Text] [Related]
12. [Subacute cutaneous lupus erythematosus induced by terbinafine].
Amitay-Layish I; Feuerman H; David M
Harefuah; 2006 Jul; 145(7):480-2, 552. PubMed ID: 16900733
[TBL] [Abstract][Full Text] [Related]
13. Terbinafine-induced subacute cutaneous lupus erythematosus.
Bonsmann G; Schiller M; Luger TA; Ständer S
J Am Acad Dermatol; 2001 Jun; 44(6):925-31. PubMed ID: 11369902
[TBL] [Abstract][Full Text] [Related]
14. Rowell's syndrome induced by terbinafine.
Murad A; Shudell E; Mulligan N
BMJ Case Rep; 2015 May; 2015():. PubMed ID: 26021384
[TBL] [Abstract][Full Text] [Related]
15. [Terbinafine-induced Stevens-Johnson syndrome and aggravation of systemic lupus erythematosus].
Terrab Z; El Ouazzani T; Zouhair K; El Kabli H; Lakhdar H
Ann Dermatol Venereol; 2006 May; 133(5 Pt 1):463-6. PubMed ID: 16760836
[TBL] [Abstract][Full Text] [Related]
16. Terbinafine-induced subacute cutaneous lupus erythematosus.
Farhi D; Viguier M; Cosnes A; Reygagne P; Dubertret L; Revuz J; Roujeau JC; Bachelez H
Dermatology; 2006; 212(1):59-65. PubMed ID: 16319476
[TBL] [Abstract][Full Text] [Related]
17. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
Ornstein DL; Ely P
J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
[No Abstract] [Full Text] [Related]
18. Acute generalized exanthematous pustulosis associated with oral terbinafine.
Hall AP; Tate B
Australas J Dermatol; 2000 Feb; 41(1):42-5. PubMed ID: 10715900
[TBL] [Abstract][Full Text] [Related]
19. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases.
Hill VA; Chow J; Cowley N; Marsden RA
Br J Dermatol; 2003 May; 148(5):1056. PubMed ID: 12786843
[No Abstract] [Full Text] [Related]
20. Hypersensitivity syndrome reaction to oral terbinafine.
Gupta AK; Porges AJ
Australas J Dermatol; 1998 Aug; 39(3):171-2. PubMed ID: 9737044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
